Value demonstration Small, specialized health economics and outcomes research firm with 27 years in market and Fortune 100 experience presents a clear opportunity to expand service adoption among mid-to-large biopharma and medical device companies seeking robust value propositions, pricing, and market access strategies.

Lifecycle value Opportunity to upsell end-to-end evidence generation and publication services that support product lifecycle management, payer adoption, and reimbursement strategies for clients expanding or launching new therapies.

Global reach Leverage an international network across payer, provider, policy, and academic communities to position EPI-Q as a partner for global market access studies and region-specific value dossiers.

Tech-enabled delivery Utilize existing tech stack and digital research capabilities to pitch scalable, data-driven projects, including real-world evidence generation and value communications, with emphasis on efficient delivery and credibility.

Team credibility Highlight seasoned multidisciplinary staff including clinicians, methodologists, health economists, and policy experts as a differentiator for clients needing credible, real-world evidence to inform decision-makers.